Tremfya 200 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FE1DH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,021
Award facts
- Contract value 100% obligated
- $29,021.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,021.04 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. This delivery order is expected to be completed by October 17, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has established itself through multiple competitively awarded contracts with the DLA, supplying an extensive portfolio of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across numerous therapeutic domains. This current delivery order for TREMFYA, a specialized immunological medication, demonstrates the company's continued role in fulfilling federal medical supply requirements through the DLA's Medical Supply Chain network.
Quick answers
Who was awarded contract SPE2DB25FE1DH?
SPE2DB25FE1DH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FE1DH worth?
The government has obligated $29,021 on SPE2DB25FE1DH.
Is contract SPE2DB25FE1DH an order under another contract?
Yes. SPE2DB25FE1DH is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE1DH competed?
The extent of competition for SPE2DB25FE1DH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award